Lonza Group AG - ESG Rating & Company Profile powered by AI
The ESG score covers 17 United Nations SDGs including: 'Affordable & Clean Energy', 'Climate Action' and 'Peace, Justice & Strong Institutions'. If you work at Lonza Group AG and you would like to use your ESG rating, please contact us. Browse to the end of the page for potential risks for Lonza Group AG based on sector, geography and marketcap.
Lonza Group AG in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 1.8; made up of an environmental score of 0.0, social score of 2.0 and governance score of 3.4.
1.8
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1617 | Berry Genomics Co Ltd | 1.9 | Low |
| 1617 | scPharmaceuticals Inc | 1.9 | Low |
| 1631 | Lonza Group AG | 1.8 | Low |
| 1631 | Cannabis Global, Inc. | 1.8 | Low |
| 1631 | Cannabis Strategic Ventures | 1.8 | Low |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Lonza Group AG have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Lonza Group AG disclose current and historical energy intensity?
Sign up for free to unlockDoes Lonza Group AG report the average age of the workforce?
Sign up for free to unlockDoes Lonza Group AG reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Lonza Group AG disclose its ethnicity pay gap?
Sign up for free to unlockDoes Lonza Group AG disclose cybersecurity risks?
Sign up for free to unlockDoes Lonza Group AG offer flexible work?
Sign up for free to unlockDoes Lonza Group AG have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Lonza Group AG disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Lonza Group AG conduct supply chain audits?
Sign up for free to unlockDoes Lonza Group AG disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Lonza Group AG conduct 360 degree staff reviews?
Sign up for free to unlockDoes Lonza Group AG disclose the individual responsible for D&I?
Sign up for free to unlockDoes Lonza Group AG disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Lonza Group AG disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Lonza Group AG disclose water use targets?
Sign up for free to unlockDoes Lonza Group AG have careers partnerships with academic institutions?
Sign up for free to unlockDid Lonza Group AG have a product recall in the last two years?
Sign up for free to unlockDoes Lonza Group AG disclose incidents of discrimination?
Sign up for free to unlockDoes Lonza Group AG allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Lonza Group AG issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Lonza Group AG disclose parental leave metrics?
Sign up for free to unlockDoes Lonza Group AG disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Lonza Group AG disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Lonza Group AG disclose the pay ratio of women to men?
Sign up for free to unlockDoes Lonza Group AG support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Lonza Group AG disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Lonza Group AG reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Lonza Group AG involved in embryonic stem cell research?
Sign up for free to unlockDoes Lonza Group AG disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Lonza Group AG disclose its waste policy?
Sign up for free to unlockDoes Lonza Group AG report according to TCFD requirements?
Sign up for free to unlockDoes Lonza Group AG disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Lonza Group AG disclose energy use targets?
Sign up for free to unlockDoes Lonza Group AG disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Lonza Group AG have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Lonza Group AG
These potential risks are based on the size, segment and geographies of the company.
Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia and New Zealand, and internationally. It operates through Biologics, Small Molecules, Cell & Gene, and Capsules & Health Ingredients segments. The Biologics segment engages in the contract development and manufacturing of biopharmaceuticals for clinical and commercial manufacturing needs throughout the product lifecycle, including drug substance and drug product manufacturing. The Small Molecules segment operates as an integrated development and manufacturing service provider for small molecule drug substances and their intermediates. It supports customers across various aspects of design, development, and manufacturing. The Cell & Gene segment develops technologies and platforms that industrialize the manufacturing processes and production of cell and gene therapies. It also offers contract development and manufacturing services, and regulatory support for a range of allogeneic and autologous cell therapies, and exosome-based therapies, as well as viral vector gene therapies. In addition, this segment provides specialty raw materials and enabling technology solutions in cell and gene therapy, injectable drugs, vaccines, and bio-manufacturing markets. The Capsules & Health Ingredients segment offers capsules, dosage form solutions, and health ingredients for pharmaceutical and nutraceutical customers. The company was founded in 1897 and is headquartered in Basel, Switzerland.